Molecular mechanisms of chronic dietary cholesterol-driven remodeling of LDLR protein fate
Received date: 2026-06-23
Online published: 2026-06-25
The hepatic low-density lipoprotein receptor (LDLR) mediates the clearance of circulating low-density lipoprotein (LDL) and is a key determinant of cholesterol homeostasis. However, how nutritional cues such as chronic dietary cholesterol regulate LDLR intracellular trafficking and protein turnover through specific molecular switches remains poorly understood. Dr. Alan Saltiel’s team at the University of California San Diego discovered a cholesterol stress-response pathway mediated by Ral GTPases, revealing a new mechanism by which dietary cholesterol reshapes LDLR protein fate and thereby affects cholesterol homeostasis. The study found that chronic dietary cholesterol loading or sustained Ral activation reduces LDLR protein levels. Mechanistically, chronic cholesterol loading activates Ral GTPases by increasing RAS activity. Activated Ral, on the one hand, recruits the RalBP1-REPS1 endocytic complex to promote LDLR internalization and lysosomal trafficking while inhibiting LDLR recycling back to the cell surface. On the other hand, Ral activation promotes the processing and lysosomal localization of cathepsin A (CTSA) and reduces its extracellular secretion, thereby enhancing CTSA-mediated LDLR degradation. This process occurs independently of LDLR transcriptional regulation or PCSK9-mediated LDLR degradation. Inhibition of CTSA stabilizes LDLR protein and promotes LDL uptake and plasma cholesterol clearance. Human genetic analyses further indicate that key components of this pathway are associated with plasma lipid levels and cardiovascular disease risk. This study reveals a dietary cholesterol-activated Ral-CTSA-LDLR protein homeostasis pathway, providing a new mechanistic framework for understanding how nutritional stress disrupts cholesterol metabolism and identifying a potential therapeutic target distinct from existing treatment strategies for hypercholesterolemia and cardiovascular disease.
Key words: cholesterol homeostasis; cardiovascular disease; LDLR; Ral GTPases; CTSA
Xue Feng . Molecular mechanisms of chronic dietary cholesterol-driven remodeling of LDLR protein fate[J]. Hereditas(Beijing), 2026 , 48(8) : 759 -763 . DOI: 10.16288/j.yczz.26-155
| [1] | Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA, 2016, 316(12): 1289-1297. |
| [2] | Domanski MJ, Tian X, Wu CO, Reis JP, Dey AK, Gu Y, Zhao LH, Bae S, Liu K, Hasan AA, Zimrin D, Farkouh ME, Hong CC, Lloyd-Jones DM, Fuster V. Time course of LDL cholesterol exposure and cardiovascular disease event risk. J Am Coll Cardiol, 2020, 76(13): 1507-1516. |
| [3] | Brautbar A, Ballantyne CM. Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat Rev Cardiol, 2011, 8(5): 253-265. |
| [4] | Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell, 2015, 161(1): 161-172. |
| [5] | Penson PE, Pirro M, Banach M. LDL-C: lower is better for longer-even at low risk. BMC Med, 2020, 18(1): 320. |
| [6] | Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol, 2020, 21(4): 225-245. |
| [7] | Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat, 1992, 1(6): 445-466. |
| [8] | Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell, 2006, 124(1): 35-46. |
| [9] | Horton JD, Cohen JC, Hobbs HH. Molecular biology of PCSK9:its role in LDL metabolism. Trends Biochem Sci, 2007, 32(2): 71-77. |
| [10] | Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science, 2009, 325(5936): 100-104. |
| [11] | Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol, 2009, 29(4): 431-438. |
| [12] | Applebaum-Bowden D, Haffner SM, Hartsook E, Luk KH, Albers JJ, Hazzard WR. Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. Am J Clin Nutr, 1984, 39(3): 360-367. |
| [13] | Feingold KR. The effect of diet on cardiovascular disease and lipid and lipoprotein levels. In: Endotext. Feingold KR, Editor-in-chief, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, eds. National Library of Medicine. 2000. |
| [14] | Horton JD, Cuthbert JA, Spady DK. Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels. J Clin Invest, 1993, 92(2): 743-749. |
| [15] | Lecerf JM, de Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk. Br J Nutr, 2011, 106(1): 6-14. |
| [16] | Feng X, Zhang S, Wang YQ, Kurlagunda T, Sit A, Jaishankar P, Yang PS, Sakane S, Park SY, Wisessaowapak C, Nguyen K, Yan J, Pothulu H, Dinh C, Chu F, Ren YY, Zhang BC, Secrest P, Han LM, Hung CW, Veeragandham P, Skorobogatko Y, Kisseleva T, Gordts PLSM, Renslo AR, Zhao P, Majithia AR, Saltiel AR. Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover. Nature, 2026, doi: 10.1038/s41586-026-10697-z. |
| [17] | Seyrantepe V, Hinek A, Peng JZ, Fedjaev M, Ernest S, Kadota Y, Canuel M, Itoh K, Morales CR, Lavoie J, Tremblay J, Pshezhetsky AV. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation, 2008, 117(15): 1973-1981. |
| [18] | Galjart NJ, Morreau H, Willemsen R, Gillemans N, Bonten EJ, d’Azzo A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem, 1991, 266, 14754-14762. |
| [19] | Timur ZK, Demir SA, Seyrantepe V. Lysosomal cathepsin A plays a significant role in the processing of endogenous bioactive peptides. Front Mol Biosci, 2016, 3: 68. |
| [20] | Ketterer S, Gomez-Auli A, Hillebrand LE, Petrera A, Ketscher A, Reinheckel T. Inherited diseases caused by mutations in cathepsin protease genes. FEBS J, 2017, 284(10): 1437-1454. |
/
| 〈 |
|
〉 |